Tradestie Institutional Equity Comparison Engine

CRBP vs OBIO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

OBIO Overall Edge

OBIO Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Orchestra BioMed Holdings, Inc. Ordinary Shares (OBIO) driven by superior Momentum & Technical, Options & Structure while CRBP counters with relative strength in Growth & Margin. Fundamentally, CRBP trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus OBIO at N/M Forward P/E and -195.4% operating margin (-89.4% YoY). In options structure, CRBP sits in BREAKDOWN (66th %ile IV; Dealer Gamma Walls on Pro) against OBIO sits in BREAKOUT (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CRBP N/M vs OBIO N/M Fwd P/E
Growth & Margin Winner CRBP
Op Margin 0.0% vs -195.4% ยท YoY -100.0% vs -89.4%
Momentum & Technical Winner OBIO
1Y -69.5% vs +70.3% ยท 52W Pos 6% vs 92%
Options & Structure Winner OBIO
BREAKDOWN (66th %ile IV) vs BREAKOUT (<1st %ile IV)
CRBP NASDAQ
Corbus Pharmaceuticals Holdings, Inc.
Pharmaceutical Preparations
$3.38
-0.44% 1D
Market Cap $69.9M
1M Return -25.33%
1Y Return -69.51%
Forward P/E N/M
Unified AI Score
45.0 / 100 HOLD
Tech 43.0 Fund 54.0 Flow 69.0 Mom 64.0
OBIO NASDAQ
Orchestra BioMed Holdings, Inc. Ordinary Shares
Surgical & Medical Instruments & Apparatus
$7.12
-1.79% 1D
Market Cap $570.6M
1M Return +30.64%
1Y Return +70.33%
Forward P/E N/M
Unified AI Score
37.5 / 100 SELL
Tech 15.0 Fund 36.0 Flow 55.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CRBP -69.51% OBIO +70.33% Spread: +139.84 pp (OBIO Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CRBP Revenue OBIO Revenue CRBP Op. Margin OBIO Op. Margin Margin Edge
FY2018 $0M N/A -1176.8% N/A CRBP
FY2019 $40M N/A -213.3% N/A CRBP
FY2020 $0M N/A -3119.2% N/A CRBP
FY2021 $0M N/A -6350.1% N/A CRBP
FY2022 N/A $0M N/A -924.3% OBIO
FY2023 N/A $0M N/A -1866.2% OBIO
FY2024 N/A $0M N/A -2437.5% OBIO
FY2025 N/A $30M N/A -154.7% OBIO

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CRBP (4) vs OBIO (4)
Institutional Metric CRBP OBIO Criterion Row Winner
Market Capitalization Scale $69.9M $570.6M Larger Scale OBIO
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -100.0% -89.4% Higher Growth OBIO
Operating Margin (TTM) Profitability 0.0% -195.4% Higher Margin CRBP
Net Profit Margin Profitability 0.0% -182.5% Higher Margin CRBP
Return on Equity (ROE) Capital Efficiency -131.5% -182.3% Higher ROE CRBP
52-Week Range Position Momentum 6% ($3โ€“$13) 92% ($3โ€“$7) Stronger Trend OBIO
Beta / 30D Volatility Risk Regime 1.93ฮฒ ยท 121% Vol 1.15ฮฒ ยท 82% Vol Lower Realized Risk OBIO
Unified Institutional Score Composite Signal 45.0 / 100 (HOLD) 37.5 / 100 (SELL) Higher Composite CRBP

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CRBP vs OBIO Buy Guide
CRBP BREAKDOWN
58d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 66th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live CRBP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
OBIO BREAKOUT
32d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live OBIO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CRBP nor OBIO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.